Literature DB >> 19401122

Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study).

Miquel Gómez1, Vicente Valle, Fernando Arós, Ginés Sanz, Joan Sala, Miquel Fiol, Jordi Bruguera, Roberto Elosua, Lluís Molina, Helena Martí, M Isabel Covas, Andrés Rodríguez-Llorián, Montserrat Fitó, Miguel A Suárez-Pinilla, Rocío Amezaga, Jaume Marrugat.   

Abstract

INTRODUCTION AND
OBJECTIVES: To determine the prevalence of acute myocardial infarction (AMI) without classical risk factors, and to ascertain whether affected patients exhibit a higher prevalence of emergent risk factors and whether the presence of specific emergent risk factors influence prognosis at 6 months.
METHODS: The FORTIAM (Factores Ocultos de Riesgo Tras un Infarto Agudo de Miocardio) study is a multicenter cohort study that includes 1371 AMI patients who were admitted within 24 hours of symptom onset. Strict definitions were used for classical risk factors and the concentrations of the following markers were determined: lipoprotein (a) [Lp(a)], oxidized low-density lipoprotein (oxLDL), high-sensitivity C-reactive protein, fibrinogen, homocysteine and antibody to Chlamydia. The end-points observed during the 6-month follow-up were death, angina and re-infarction.
RESULTS: The prevalence of AMI without classical risk factors was 8.0%. The absence of classical risk factors did not affect the 6-month prognosis. The only emergent risk factors independently associated with a poorer prognosis were the Lp(a) and oxLDL concentrations. Cut-points were determined using smoothing splines: 60 mg/ dL for Lp(a) and 74 U/L for oxLDL. The associated hazard ratios, adjusted for age, sex and classical risk factors, were 1.40 (95% confidence interval, 1.06-1.84 ) and 1.48 (95% confidence interval, 1.06-2.06), respectively.
CONCLUSIONS: The proportion of AMI patients without classical risk factors was low and their prognosis was similar to that in other AMI patients. Both oxLDL and Lp(a) concentrations were independently associated with a poorer 6-month prognosis, irrespective of the presence of classical risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401122     DOI: 10.1016/s1885-5857(09)71664-0

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  8 in total

Review 1.  The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events.

Authors:  Serban Maierean; Richard Webb; Maciej Banach; Mohsen Mazidi
Journal:  Eur Heart J Open       Date:  2022-06-14

2.  Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection.

Authors:  Timothy Guilford; Devin Morris; Dennis Gray; Vishwanath Venketaraman
Journal:  HIV AIDS (Auckl)       Date:  2010-10-29

Review 3.  South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.

Authors:  Latha Palaniappan; Arun Garg; Enas Enas; Henrietta Lewis; Sehrish Bari; Martha Gulati; Cristina Flores; Ashish Mathur; Cesar Molina; Jagat Narula; Shahid Rahman; Jennifer Leng; Francesca Gany
Journal:  J Community Health       Date:  2018-12

Review 4.  Advances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular Prevention.

Authors:  Montserrat Fitó; Olle Melander; José Alfredo Martínez; Estefanía Toledo; Christian Carpéné; Dolores Corella
Journal:  Int J Mol Sci       Date:  2016-09-02       Impact factor: 5.923

5.  Serum Lipoprotein (a) Levels in Black South African Type 2 Diabetes Mellitus Patients.

Authors:  Jim Joseph; Farzana Ganjifrockwala; Grace George
Journal:  Oxid Med Cell Longev       Date:  2016-10-19       Impact factor: 6.543

Review 6.  Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease.

Authors:  Shen Gao; Jing Liu
Journal:  Chronic Dis Transl Med       Date:  2017-05-25

7.  DUSP1 Is a Potential Marker of Chronic Inflammation in Arabs with Cardiovascular Diseases.

Authors:  Abdelkrim Khadir; Sina Kavalakatt; Mohammed Dehbi; Monira Alarouj; Abdullah Bennakhi; Ali Tiss; Naser Elkum
Journal:  Dis Markers       Date:  2018-12-13       Impact factor: 3.434

8.  High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients.

Authors:  I Dewa Gde Dwi Sumarjaya; I Ketut Badjra Nadha; Anak Agung Wiradewi Lestari
Journal:  Vasc Health Risk Manag       Date:  2020-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.